UL
Ulys LLC Portfolio holdings
AUM
$25.4M
This Quarter Return
-0.47%
1 Year Return
+201.03%
3 Year Return
-31.51%
5 Year Return
-50.88%
10 Year Return
–
AUM
$64.7M
AUM Growth
–
Cap. Flow
+$64.7M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Lexicon Pharmaceuticals
LXRX
|
$64.6M |
| 2 |
CERE
CERES, INC. COMMON STOCK NEW
CERE
|
$97K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Lexicon Pharmaceuticals
LXRX
$400M
| $64.6M | 99.85% | +29,782,609 | New | +$64.6M |
|
|
CERE
2
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| $97K | 0.15% | +31,131 | New | +$97K |
|